APA (7th ed.) Citation

Hohneck, A., Rosenkaimer, S. L., Sieburg, T., Holzwarth, J., Hofheinz, R., Akın, I., . . . Gerhards, S. (2021). Prognostic impact of pretherapeutic hemoglobin levels on all-cause mortality in cardiooncology. Anticancer research, 41(1), . https://doi.org/10.21873/anticanres.14785

Chicago Style (17th ed.) Citation

Hohneck, Anna, Stephanie L. Rosenkaimer, Tina Sieburg, Jakob Holzwarth, Ralf-Dieter Hofheinz, Ibrahim Akın, Martin Borggrefe, and Stefan Gerhards. "Prognostic Impact of Pretherapeutic Hemoglobin Levels on All-cause Mortality in Cardiooncology." Anticancer Research 41, no. 1 (2021). https://doi.org/10.21873/anticanres.14785.

MLA (9th ed.) Citation

Hohneck, Anna, et al. "Prognostic Impact of Pretherapeutic Hemoglobin Levels on All-cause Mortality in Cardiooncology." Anticancer Research, vol. 41, no. 1, 2021, https://doi.org/10.21873/anticanres.14785.